US Stock MarketDetailed Quotes
ADPT Adaptive Biotechnologies
- 6.555
- +0.255+4.05%
Trading Dec 16 12:09 ET
967.38MMarket Cap-4.89P/E (TTM)
6.620High6.130Low234.60KVolume6.290Open6.300Pre Close1.52MTurnover0.27%Turnover RatioLossP/E (Static)147.58MShares7.06752wk High4.32P/B576.69MFloat Cap2.28052wk Low--Dividend TTM87.98MShs Float71.250Historical High--Div YieldTTM7.78%Amplitude2.280Historical Low6.488Avg Price1Lot Size
Adaptive Biotechnologies Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 22.46%46.44M | -11.72%43.19M | 11.23%41.87M | -8.11%170.28M | -17.05%45.78M | -20.72%37.92M | 12.06%48.93M | -2.52%37.65M | 20.06%185.31M | 45.53%55.2M |
| Operating revenue | 22.46%46.44M | -11.72%43.19M | 11.23%41.87M | -8.11%170.28M | -17.05%45.78M | -20.72%37.92M | 12.06%48.93M | -2.52%37.65M | 20.06%185.31M | 45.53%55.2M |
| Cost of revenue | -13.85%16.67M | 7.86%19.32M | -3.37%18.05M | 30.47%75.55M | 18.25%19.62M | 29.78%19.35M | 35.47%17.91M | 41.61%18.68M | 17.46%57.91M | 15.55%16.59M |
| Gross profit | 60.28%29.77M | -23.03%23.87M | 25.60%23.82M | -25.65%94.72M | -32.22%26.17M | -43.59%18.57M | 1.90%31.02M | -25.41%18.97M | 21.28%127.4M | 63.78%38.61M |
| Operating expense | -10.25%62.4M | -18.83%63.99M | -4.69%72.58M | -9.54%296.33M | -7.70%71.81M | -11.26%69.53M | -4.95%78.83M | -13.94%76.16M | 4.32%327.59M | -8.66%77.8M |
| Selling and administrative expenses | -6.80%37.81M | -17.25%38.21M | -2.84%41.92M | -6.31%172.51M | -7.61%42.63M | -4.02%40.57M | 1.52%46.17M | -14.13%43.14M | 8.33%184.13M | -7.79%46.14M |
| -Selling and marketing expense | 0.28%20.55M | -14.90%20.31M | 0.05%22.32M | -7.35%88.58M | -7.63%21.91M | -4.74%20.49M | -1.68%23.87M | -14.51%22.31M | 0.14%95.6M | -11.16%23.72M |
| -General and administrative expense | -14.03%17.26M | -19.76%17.9M | -5.92%19.6M | -5.19%83.93M | -7.59%20.73M | -3.28%20.08M | 5.20%22.3M | -13.72%20.83M | 18.82%88.53M | -3.93%22.43M |
| Research and development costs | -15.32%24.16M | -21.35%25.35M | -7.23%30.25M | -13.85%122.12M | -7.93%28.75M | -19.98%28.53M | -12.96%32.24M | -13.84%32.6M | -0.41%141.76M | -10.02%31.22M |
| Depreciation amortization depletion | 0.00%428K | 0.24%424K | 0.95%423K | 0.00%1.7M | 0.00%429K | 0.00%428K | 0.00%423K | 0.00%419K | 0.00%1.7M | 0.00%429K |
| -Depreciation and amortization | 0.00%428K | 0.24%424K | 0.95%423K | 0.00%1.7M | 0.00%429K | 0.00%428K | 0.00%423K | 0.00%419K | 0.00%1.7M | 0.00%429K |
| Operating profit | 35.96%-32.63M | 16.11%-40.11M | 14.74%-48.76M | -0.71%-201.61M | -16.47%-45.64M | -12.16%-50.96M | 8.92%-47.82M | 9.31%-57.19M | 4.20%-200.19M | 36.38%-39.19M |
| Net non-operating interest income expense | -15.08%535K | 15,185.71%1.07M | 342.41%1.23M | 1,051.10%1.73M | 262.87%1.6M | 462.50%630K | -98.33%7K | -287.08%-507K | -110.91%-182K | -511.30%-983K |
| Non-operating interest income | -18.87%3.47M | 4.26%3.77M | 39.62%4.22M | 282.91%15.53M | 77.29%4.61M | 459.74%4.28M | 764.11%3.61M | 1,015.87%3.02M | 143.17%4.06M | 988.70%2.6M |
| Non-operating interest expense | -19.52%2.94M | -25.21%2.7M | -15.24%2.99M | 225.63%13.8M | -15.98%3.01M | 459.26%3.65M | --3.61M | --3.53M | --4.24M | --3.59M |
| Other net income (expense) | -7.21M | -25.43M | ||||||||
| Special income (charges) | --0 | ---7.21M | ---- | ---25.43M | ---25.43M | --0 | --0 | ---- | --0 | ---- |
| -Less:Impairment of capital assets | --0 | --7.21M | ---- | --25.43M | --25.43M | --0 | --0 | ---- | --0 | ---- |
| Income before tax | 36.22%-32.1M | 3.27%-46.25M | 17.62%-47.53M | -12.45%-225.3M | -72.94%-69.47M | -11.05%-50.33M | 8.20%-47.81M | 8.12%-57.7M | 3.34%-200.37M | 34.53%-40.17M |
| Income tax | ||||||||||
| Net income | 36.22%-32.1M | 3.27%-46.25M | 17.62%-47.53M | -12.45%-225.3M | -72.94%-69.47M | -11.05%-50.33M | 8.20%-47.81M | 8.12%-57.7M | 3.34%-200.37M | 34.53%-40.17M |
| Net income continuous Operations | 36.22%-32.1M | 3.27%-46.25M | 17.62%-47.53M | -12.45%-225.3M | -72.94%-69.47M | -11.05%-50.33M | 8.20%-47.81M | 8.12%-57.7M | 3.34%-200.37M | 34.53%-40.17M |
| Minority interest income | 0.00%-26K | -2,500.00%-26K | -2,500.00%-26K | 69.49%-54K | 36.59%-26K | 31.58%-26K | 97.37%-1K | -1K | -831.58%-177K | -153.95%-41K |
| Net income attributable to the parent company | 36.24%-32.07M | 3.32%-46.22M | 17.66%-47.51M | -12.52%-225.25M | -73.05%-69.44M | -11.08%-50.3M | 8.14%-47.81M | 8.12%-57.7M | 3.42%-200.19M | 34.68%-40.13M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 36.24%-32.07M | 3.32%-46.22M | 17.66%-47.51M | -12.52%-225.25M | -73.05%-69.44M | -11.08%-50.3M | 8.14%-47.81M | 8.03%-57.7M | 3.42%-200.19M | 34.68%-40.13M |
| Basic earnings per share | 37.14%-0.22 | 6.06%-0.31 | 17.50%-0.33 | -11.43%-1.56 | -71.43%-0.48 | -9.37%-0.35 | 10.81%-0.33 | 9.09%-0.4 | 5.41%-1.4 | 34.88%-0.28 |
| Diluted earnings per share | 37.14%-0.22 | 6.06%-0.31 | 17.50%-0.33 | -11.43%-1.56 | -71.43%-0.48 | -9.37%-0.35 | 10.81%-0.33 | 9.09%-0.4 | 5.41%-1.4 | 34.88%-0.28 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data